Skip to main content
All lobbying filings

HOLLAND & KNIGHT LLP

Lobbying for PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Informal coalition of health and consumer organizations and sunscreen industry companies

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $70,000.00 income · posted Apr 13, 2025

Official filing document

 Lobbying activity 1
Medical/Disease Research/Clinical Labs

Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2026 House and Senate appropriations for the Food and Drug Administration; skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); nomination of new HHS and FDA leadership.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem